Drug Profile
DN 101
Alternative Names: Asentar; Calcitriol - Novacea; DN-101Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Novacea
- Class Antipsoriatics; Chemoprotectants; Dihydroxycholecalciferols; Osteoporosis therapies; Small molecules; Vitamin D analogues
- Mechanism of Action Vitamin D3 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Myelodysplastic syndromes; Non-small cell lung cancer; Pancreatic cancer; Prostate cancer
Most Recent Events
- 11 Sep 2008 Discontinued - Phase-I/II for Non-small cell lung cancer in USA (PO)
- 11 Sep 2008 Discontinued - Phase-II for Pancreatic cancer in USA (PO)
- 11 Sep 2008 Discontinued - Phase-III for Prostate cancer in Canada (PO)